Sosmitha Girisa Selected Research

Sosmitha Girisa Research Topics

Disease

36	Neoplasms (Cancer) 03/2024 - 12/2018
10	Inflammation (Inflammations) 11/2023 - 01/2020
9	Chronic Disease (Chronic Diseases) 04/2023 - 01/2020
6	Neoplasm Metastasis (Metastasis) 02/2024 - 02/2019
4	Carcinogenesis 12/2021 - 12/2018
3	Mouth Neoplasms (Oral Cancer) 01/2024 - 04/2021
3	Lung Neoplasms (Lung Cancer) 03/2022 - 12/2020
2	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 01/2023
2	Communicable Diseases (Infectious Diseases) 03/2023 - 12/2021
2	Infections 01/2021 - 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2023
1	Arthritis (Polyarthritis) 03/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2023
1	Autoimmune Diseases (Autoimmune Disease) 03/2023
1	Skin Diseases (Skin Disease) 03/2023
1	Hemoglobinopathies 03/2023
1	Hypertension (High Blood Pressure) 03/2023
1	Obesity 03/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 10/2022
1	Esophageal Neoplasms (Esophageal Cancer) 09/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	COVID-19 11/2021
1	Oral Candidiasis (Thrush) 04/2021
1	Oral Lichen Planus 04/2021
1	Gingivitis 04/2021
1	Dental Caries (Decay, Dental) 04/2021
1	Aphthous Stomatitis (Aphthous Ulcer) 04/2021
1	Periodontitis 04/2021
1	Oral Submucous Fibrosis 04/2021
1	Stomatitis 04/2021
1	Oral Leukoplakia 04/2021

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2018
6	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2020
5	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2024 - 07/2021
4	LipidsIBA 03/2024 - 07/2021
4	PhytochemicalsIBA 02/2024 - 01/2022
4	CurcuminIBA 04/2023 - 04/2021
4	CaspasesIBA 01/2022 - 12/2018
3	CateninsIBA 02/2024 - 02/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 12/2018
3	Cyclin D1IBA 01/2024 - 01/2020
3	NF-kappa B (NF-kB)IBA 03/2023 - 12/2020
3	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2021
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 12/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 12/2020
2	SurvivinIBA 01/2024 - 01/2020
2	AntioxidantsIBA 02/2023 - 11/2021
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 09/2022
2	Ligases (Synthetase)IBA 10/2022 - 02/2019
2	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 10/2022 - 01/2022
2	CarcinogensIBA 12/2021 - 01/2020
2	Nicotine FDA Link 09/2021 - 12/2020
2	TOR Serine-Threonine KinasesIBA 01/2021 - 05/2020
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2021 - 05/2020
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 02/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2024
1	Cisplatin (Platino)FDA LinkGeneric 02/2024
1	TocotrienolsIBA 02/2024
1	sulforaphaneIBA 01/2024
1	isothiocyanic acidIBA 01/2024
1	scirpusin BIBA 01/2024
1	CarbohydratesIBA 01/2024
1	EnzymesIBA 01/2024
1	ChromatinIBA 11/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023
1	Untranslated RNA (Noncoding RNA)IBA 10/2023
1	ResveratrolIBA 03/2023
1	Fluorouracil (Carac)FDA LinkGeneric 03/2023
1	Antisense OligonucleotidesIBA 03/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2023
1	Therapeutic UsesIBA 01/2023
1	AlginatesIBA 01/2023
1	calebin-AIBA 01/2023
1	VenomsIBA 01/2023
1	royal jellyIBA 01/2023
1	TriterpenesIBA 12/2022
1	Betulinic AcidIBA 12/2022
1	lupaneIBA 12/2022
1	Immune Checkpoint InhibitorsIBA 10/2022
1	embelinIBA 02/2022
1	FlavonoidsIBA 01/2022
1	InterleukinsIBA 01/2022
1	ScopoletinIBA 01/2022
1	Circular RNAIBA 12/2021
1	Small Nucleolar RNA (snoRNA)IBA 12/2021
1	DiarylheptanoidsIBA 12/2021
1	CytokinesIBA 11/2021
1	Environmental CarcinogensIBA 09/2021
1	Benzo(a)pyreneIBA 09/2021
1	N'-nitrosonornicotine (nitrosonornicotine)IBA 09/2021
1	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 09/2021
1	CholesterolIBA 07/2021
1	Glucose (Dextrose)FDA LinkGeneric 07/2021
1	ApigeninIBA 02/2021

Therapy/Procedure

15	Therapeutics 03/2024 - 12/2018
4	Drug Therapy (Chemotherapy) 01/2024 - 01/2021
2	Immunotherapy 01/2023 - 10/2022